Management of hemorrhage complicated by novel oral anticoagulants in the emergency department: Case report from the northwestern emergency medicine residency

Amy Kiraly, Abbie Lyden, Usha Periyanayagam, Jennifer Chan, Peter Pang

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Anticoagulation has long complicated the care of hemorrhage in the emergency department and other acute care settings. With the advent of novel anticoagulants such as direct thrombin inhibitors and direct factor Xa inhibitors, the absence of any direct antidote for these medications presents new and difficult challenges in the management of hemorrhagic complications in these patients. We present 2 cases of patients with hemorrhagic complications taking novel oral anticoagulants, their management, and outcomes.

Original languageEnglish (US)
Pages (from-to)300-306
Number of pages7
JournalAmerican Journal of Therapeutics
Volume20
Issue number3
DOIs
StatePublished - May 2013
Externally publishedYes

Fingerprint

Emergency Medicine
Internship and Residency
Anticoagulants
Hospital Emergency Service
Hemorrhage
Antidotes
Antithrombins
Factor Xa Inhibitors

Keywords

  • Anticoagulation
  • Dabigatran
  • Feiba
  • Hemorrhage
  • Prothrombin complex concentrates
  • Rivaroxaban

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Management of hemorrhage complicated by novel oral anticoagulants in the emergency department : Case report from the northwestern emergency medicine residency. / Kiraly, Amy; Lyden, Abbie; Periyanayagam, Usha; Chan, Jennifer; Pang, Peter.

In: American Journal of Therapeutics, Vol. 20, No. 3, 05.2013, p. 300-306.

Research output: Contribution to journalArticle

@article{59b868e2f42c477d98895db43dd8ad8a,
title = "Management of hemorrhage complicated by novel oral anticoagulants in the emergency department: Case report from the northwestern emergency medicine residency",
abstract = "Anticoagulation has long complicated the care of hemorrhage in the emergency department and other acute care settings. With the advent of novel anticoagulants such as direct thrombin inhibitors and direct factor Xa inhibitors, the absence of any direct antidote for these medications presents new and difficult challenges in the management of hemorrhagic complications in these patients. We present 2 cases of patients with hemorrhagic complications taking novel oral anticoagulants, their management, and outcomes.",
keywords = "Anticoagulation, Dabigatran, Feiba, Hemorrhage, Prothrombin complex concentrates, Rivaroxaban",
author = "Amy Kiraly and Abbie Lyden and Usha Periyanayagam and Jennifer Chan and Peter Pang",
year = "2013",
month = "5",
doi = "10.1097/MJT.0b013e3182878d18",
language = "English (US)",
volume = "20",
pages = "300--306",
journal = "American Journal of Therapeutics",
issn = "1075-2765",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Management of hemorrhage complicated by novel oral anticoagulants in the emergency department

T2 - Case report from the northwestern emergency medicine residency

AU - Kiraly, Amy

AU - Lyden, Abbie

AU - Periyanayagam, Usha

AU - Chan, Jennifer

AU - Pang, Peter

PY - 2013/5

Y1 - 2013/5

N2 - Anticoagulation has long complicated the care of hemorrhage in the emergency department and other acute care settings. With the advent of novel anticoagulants such as direct thrombin inhibitors and direct factor Xa inhibitors, the absence of any direct antidote for these medications presents new and difficult challenges in the management of hemorrhagic complications in these patients. We present 2 cases of patients with hemorrhagic complications taking novel oral anticoagulants, their management, and outcomes.

AB - Anticoagulation has long complicated the care of hemorrhage in the emergency department and other acute care settings. With the advent of novel anticoagulants such as direct thrombin inhibitors and direct factor Xa inhibitors, the absence of any direct antidote for these medications presents new and difficult challenges in the management of hemorrhagic complications in these patients. We present 2 cases of patients with hemorrhagic complications taking novel oral anticoagulants, their management, and outcomes.

KW - Anticoagulation

KW - Dabigatran

KW - Feiba

KW - Hemorrhage

KW - Prothrombin complex concentrates

KW - Rivaroxaban

UR - http://www.scopus.com/inward/record.url?scp=84880071979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880071979&partnerID=8YFLogxK

U2 - 10.1097/MJT.0b013e3182878d18

DO - 10.1097/MJT.0b013e3182878d18

M3 - Article

C2 - 23584314

AN - SCOPUS:84880071979

VL - 20

SP - 300

EP - 306

JO - American Journal of Therapeutics

JF - American Journal of Therapeutics

SN - 1075-2765

IS - 3

ER -